utilized as an alternative surgical treatment to a distal pancreatectomy to preserve pancreatic parenchyma. The CP has declined in popularity due concerns of increased morbidity specically related to postoperative pancreatic leak and stula relative to non-parenchymal sparing techniques [3]. As imaging technology of computed tomography (CT) and magnetic resonance (MR) scans continue to improve, detec­tion rate of small, mid-body pancreatic lesions increases and becomes a more rele­vant clinical question in daily clinical practice of pancreatic surgery. Additionally, nuclear medicine modality such as Dotatate scan has demonstrated the ability to improve detection of small pancreatic neuroendocrine tumors as well [4, 5]. It stands to reason that as detection of these lesions becomes more common, a central pancreatectomy may have a developing role in the management of these patients.